Are National Parks the Next Destination for Illegal Immigrant Tent Cities?
Read Jim Jordan's Response to Fulton County DA Fani Willis
Ian Sams Has a Brutal Day
'When Social Justice Replaces Actual Justice': Critics Blast Ethan Liming Death Verdict
The Biden Administration Found Asylum-Seekers It Wants to Deport
The Problems With Net Zero
This Is Who Tucker Carlson Will be Interviewing During the Second GOP Debate
The Devastating Effects Border Patrol Agents Have to Endure Because of Joe Biden's...
It's Time for GOP Debate BINGO
Border Patrol Seized Enough Fentanyl to Wipe Out the Entire U.S. Population This...
Here’s Why Missouri Will Sue a School District
We Keep Hearing This Line of Defense for Biden
New Survey Shows How Many Americans Will Get the Updated COVID-19 Vaccine
Poll Shows Iowans Are Still Undecided in GOP Primary
Why This Teacher Was Arrested Will Shock You

FDA to Approve Pfizer Vaccine for Individuals 12-15 Years Old Next Week

AP Photo/Virginia Mayo

The Food and Drug Administration (FDA) announced that Pfizer's two-dose coronavirus vaccine will be approved for individuals ages 12-15 next week. Over 100 million adults have already received the vaccination in full. 


The news is a step in the right direction in the effort to get a majority of Americans vaccinated, that was first spearheaded by the Trump administration. Still, the Biden administration has avoided committing to reopening schools in the Fall, despite overwhelming evidence that a return to traditional, in-person learning is safe.

“The clearance would be a major development in the nation’s vaccination campaign and welcome news to parents anxious to protect their children during summer activities and before the start of the next school year...Pfizer reported several weeks ago that none of the adolescents in the clinical trial who received the vaccine developed symptomatic infections, a sign of significant protection. The company announced in late March that volunteers produced strong antibody responses and experienced about the same side effects seen in people ages 16 to 25 years,” New York Times reported.


The results of Moderna's two-dose vaccine clinical trial for the same age category are still pending.

Join the conversation as a VIP Member


Trending on Townhall Videos